| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Yuan Cao, Wen Yao, Fang Che. Brief research report: WGCNA-driven identification of histone modification genes as potential biomarkers in AQP4-Associated optic neuritis. Frontiers in genetics. vol 15. 2024-09-06. PMID:39238786. |
the discovery of antibodies aqp4 and myelin oligodendrocyte glycoprotein (mog) has expanded our understanding of the pathogenesis of neuromyelitis optica. |
2024-09-06 |
2024-09-08 |
Not clear |
| Dalia L Rotstein, Mark S Freedman, Andrea Konig, Liesly Lee, Jin Luo, Colleen Maxwell, Sarah A Morrow, Helen Tremlett, Manav V Vyas, Ruth Ann Marri. Investigation of health care use and a possible prodrome before the first attack in NMOSD and MOGAD. Multiple sclerosis (Houndmills, Basingstoke, England). 2024-09-05. PMID:39234853. |
we evaluated the possibility of a prodrome in aquaporin-4 antibody positive (aqp4+) neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein antibody disease (mogad) using health administrative data. |
2024-09-05 |
2024-09-08 |
Not clear |
| Giulio Volpe, Neringa Jurkute, Gabriela Girafa, Hanna G Zimmermann, Seyedamirhosein Motamedi, Charlotte Bereuter, Lekha Pandit, Anitha D'Cunha, Michael R Yeaman, Terry J Smith, Lawrence J Cook, Alexander U Brandt, Friedemann Paul, Axel Petzold, Frederike C Oerte. Diagnostic Value of Inter-Eye Difference Metrics on OCT for Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis. Neurology(R) neuroimmunology & neuroinflammation. vol 11. issue 6. 2024-09-04. PMID:39231384. |
the diagnostic value of intereye difference (ied) metrics is high for on in patients with multiple sclerosis and aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders, but unknown in myelin oligodendrocyte glycoprotein antibody-associated on (mog-on). |
2024-09-04 |
2024-09-08 |
Not clear |
| Masaaki Niino, Noriko Isobe, Manabu Araki, Takashi Ohashi, Tomoko Okamoto, Mieko Ogino, Tatsusada Okuno, Hirofumi Ochi, Izumi Kawachi, Yuko Shimizu, Kazuya Takahashi, Hideyuki Takeuchi, Masayuki Tahara, Norio Chihara, Ichiro Nakashima, Hikoaki Fukaura, Tatsuro Misu, Yusei Miyazaki, Katsuichi Miyamoto, Masahiro Mori, Makoto Kinoshita, Yoshiki Takai, Chihiro Fujii, Mitsuru Watanabe, Kazuo Fujihar. Clinical practice guidelines for multiple sclerosis, neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease 2023 in Japan. Multiple sclerosis and related disorders. vol 90. 2024-08-25. PMID:39182455. |
clinical practice guidelines for multiple sclerosis, neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease 2023 in japan. |
2024-08-25 |
2024-08-28 |
Not clear |
| Debamita Datta, Mala Mahto, Upasna Sinha, Sushil Kuma. Indirect Immunofluorescence-Aided Detection of Antimyelin Oligodendrocyte Glycoprotein Antibodies in Neuromyelitis Optica Spectrum Disorder/Myelin Oligodendrocyte Glycoprotein-Associated Antibody Disorder: A Case Series Involving Five Patients. Annals of African medicine. 2024-08-14. PMID:39138928. |
indirect immunofluorescence-aided detection of antimyelin oligodendrocyte glycoprotein antibodies in neuromyelitis optica spectrum disorder/myelin oligodendrocyte glycoprotein-associated antibody disorder: a case series involving five patients. |
2024-08-14 |
2024-08-16 |
Not clear |
| Kimihiko Kaneko, Hiroshi Kuroda, Yuki Matsumoto, Naohiro Sakamoto, Naoya Yamazaki, Naoki Yamamoto, Shu Umezawa, Chihiro Namatame, Hirohiko Ono, Yoshiki Takai, Toshiyuki Takahashi, Juichi Fujimori, Ichiro Nakashima, Yasuo Harigaya, Hans Lassmann, Kazuo Fujihara, Tatsuro Misu, Masashi Aok. Different Complement Activation Patterns Following C5 Cleavage in MOGAD and AQP4-IgG+NMOSD. Neurology(R) neuroimmunology & neuroinflammation. vol 11. issue 5. 2024-08-12. PMID:39133885. |
in myelin oligodendrocyte glycoprotein igg-associated disease (mogad) and aquaporin-4 igg+ neuromyelitis optica spectrum disorder (aqp4+nmosd), the autoantibodies are mainly composed of igg1, and complement-dependent cytotoxicity is a primary pathomechanism in aqp4+nmosd. |
2024-08-12 |
2024-08-16 |
Not clear |
| Giuseppe Schirò, Salvatore Iacono, Giuseppe Salemi, Paolo Ragones. The pharmacological management of myelin oligodendrocyte glycoprotein-immunoglobulin G associated disease (MOGAD): an update of the literature. Expert review of neurotherapeutics. 2024-08-07. PMID:39110029. |
myelin oligodendrocyte glycoprotein-immunoglobulin g associated disease (mogad) is a clinical entity distinct from multiple sclerosis and aquaporin-4 (aqp4+)-igg-positive neuromyelitis optica spectrum disorder. |
2024-08-07 |
2024-08-09 |
Not clear |
| Elia Sech. NMOSD and MOGAD. Continuum (Minneapolis, Minn.). vol 30. issue 4. 2024-08-01. PMID:39088288. |
this article reviews the clinical features, mri characteristics, diagnosis, and treatment of aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (aqp4-nmosd) and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad). |
2024-08-01 |
2024-08-05 |
Not clear |
| Étienne Bénard-Séguin, Christopher Nielsen, Abdullah Sarhan, Abdullah Al-Ani, Antoine Sylvestre-Bouchard, Derek M Waldner, Lindsey B De Lott, Suresh Subramaniam, Fiona Costell. The Role of Artificial Intelligence in Predicting Optic Neuritis Subtypes From Ocular Fundus Photographs. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2024-08-01. PMID:39088711. |
notably, on associated with multiple sclerosis (ms on) has a good prognosis for recovery irrespective of treatment, whereas on associated with other conditions including neuromyelitis optica spectrum disorders or myelin oligodendrocyte glycoprotein antibody-associated disease is often associated with less favorable outcomes. |
2024-08-01 |
2024-08-05 |
Not clear |
| Meng-Meng Wang, Tao Huang, Jia-Xun Li, Yang Yao, Ying Chen, Kai-Kai Fu, Wen-Rong Miao, Yi Ha. Optic Neuritis Leading to Vision Loss: A Case of MOG-Associated Disease with Successful Immunotherapy. The American journal of case reports. vol 25. 2024-07-26. PMID:39054886. |
background myelin oligodendrocyte glycoprotein (mog)-associated disease (mogad) is a recently described inflammatory demyelinating disease of the central nervous system (cns), which needs to be distinguished from aquaporin-4 (aqp4)-igg-positive neuromyelitis optica spectrum disorder (aqp4-igg+nmosd) and multiple sclerosis (ms). |
2024-07-26 |
2024-07-28 |
Not clear |
| Yin Yin Tan, Seyed Ehsan Saffari, Janis Siew Noi Tye, Xuejuan Peng, Min Jie Koh, Abu Bakar Shakran Bin Mahmood, Jeanne May May Tan, Kevin Tan, Tianrong Ye. The burden of psychiatric morbidity in Multiple Sclerosis, AQP4-antibody NMOSD and MOGAD before and after neurological diagnosis. Multiple sclerosis and related disorders. vol 89. 2024-07-25. PMID:39053396. |
psychiatric comorbidities are common in multiple sclerosis (ms) and are increasingly recognised in aquaporin-4-antibody neuromyelitis optica spectrum disorders (aqp4-ab nmosd) and myelin oligodendrocyte glycoprotein-antibody associated disease (mogad). |
2024-07-25 |
2024-07-28 |
Not clear |
| Sara Samadzadeh, Rafl Adnan, Paulina Berglova, Mahdi Barzegar, Birgit Debrabant, Stine Gundtoft Roikjaer, Michael Levy, Axel Petzold, Jacqueline Palace, Eoin P Flanagan, Sara Mariotto, Soeren T Skou, Anne Froelich, Itay Lotan, Silvia Messina, Ruth Geraldes, Susanna Asseyer, Hadas Stiebel-Kalish, Frederike Cosima Oertel, Vahid Shaygannejad, Mohammad Ali Sahraian, Ho Jin Kim, Jeffrey L Bennett, Chotima Böttcher, Hanna G Zimmermann, Brian G Weinshenker, Friedemann Paul, Nasrin Asgar. Protocol of a prospective multicenter study on comorbidity impact on multiple sclerosis and antibody-mediated diseases of the central nervous system (COMMIT). Frontiers in immunology. vol 15. 2024-07-18. PMID:39021565. |
comorbidities in patients with multiple sclerosis (ms) and antibody-mediated diseases of the central nervous system (cns) including neuromyelitis optica spectrum disorder (nmosd), and myelin oligodendrocyte glycoprotein (mog)-antibody-associated disease (mogad) are common and may influence the course of their neurological disease. |
2024-07-18 |
2024-07-20 |
human |
| Carson E Moseley, Akash Virupakshaiah, Thomas G Forsthuber, Lawrence Steinman, Emmanuelle Waubant, Scott S Zamvi. MOG CNS Autoimmunity and MOGAD. Neurology(R) neuroimmunology & neuroinflammation. vol 11. issue 5. 2024-07-12. PMID:38996203. |
at one time considered a possible form of neuromyelitis optica (nmo) spectrum disorder (nmosd), it is now accepted that myelin oligodendrocyte glycoprotein (mog) antibody (ab)-associated disorder (mogad) is a distinct entity from either nmo or multiple sclerosis (ms) and represents a broad spectrum of clinical phenotypes. |
2024-07-12 |
2024-07-15 |
Not clear |
| Frederick Gyabaah, Cyrena Petersen, Emily Bateman, Abhizith Deoke. Acute-Onset Blindness in a Patient Diagnosed With Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOG-AD): A Case Report. Cureus. vol 16. issue 6. 2024-07-08. PMID:38975430. |
myelin oligodendrocyte glycoprotein antibody disease (mog-ad) poses a diagnostic challenge, often masquerading as other neurological disorders such as multiple sclerosis and aquaporin-4-positive neuromyelitis optica spectrum disorder. |
2024-07-08 |
2024-07-11 |
Not clear |
| Hyunjin Ju, Yeon Hak Chung, Soonwook Kwon, Eun Bin Cho, Kyung-Ah Park, Ju-Hong Mi. Usefulness of the MFIS-K, FSS, and FACIT-F Fatigue Scales in Korean Patients With MS, NMOSD, and MOGAD. Journal of clinical neurology (Seoul, Korea). vol 20. issue 4. 2024-07-02. PMID:38951976. |
fatigue is common in demyelinating disorders of the central nervous system (cns), including multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd), and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad). |
2024-07-02 |
2024-07-04 |
Not clear |
| Tais Estrela, Hadas Stiebel-Kalish, Leigh Rettenmaier, Amanda D Henderson, Elias Sotirchos, Yana Said, Gelareh Ahmadi, Deena A Tajfirouz, Eoin P Flanagan, Nanthaya Tisavipat, Ryan Gise, Bart K Chwalisz, John J Che. Optic Disc Cupping in Neuromyelitis Optica Spectrum Disorder, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, and Multiple Sclerosis and Its Relationship With Optical Coherence Tomography Parameters: A Multicenter Study. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2024-07-01. PMID:38946028. |
optic disc cupping in neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, and multiple sclerosis and its relationship with optical coherence tomography parameters: a multicenter study. |
2024-07-01 |
2024-07-03 |
Not clear |
| Tais Estrela, Hadas Stiebel-Kalish, Leigh Rettenmaier, Amanda D Henderson, Elias Sotirchos, Yana Said, Gelareh Ahmadi, Deena A Tajfirouz, Eoin P Flanagan, Nanthaya Tisavipat, Ryan Gise, Bart K Chwalisz, John J Che. Optic Disc Cupping in Neuromyelitis Optica Spectrum Disorder, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, and Multiple Sclerosis and Its Relationship With Optical Coherence Tomography Parameters: A Multicenter Study. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2024-07-01. PMID:38946028. |
the purpose of this study was to compare cupping in patients after on from multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd), or myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) and to investigate the relationship between cupping and retinal nerve fiber layer (rnfl) and ganglion cell complex (gcc) thinning. |
2024-07-01 |
2024-07-03 |
Not clear |
| Alessandro Cagol, Charidimos Tsagkas, Cristina Granzier. Advanced Brain Imaging in Central Nervous System Demyelinating Diseases. Neuroimaging clinics of North America. vol 34. issue 3. 2024-06-28. PMID:38942520. |
this review delves into state-of-the-art modalities applied to multiple sclerosis, neuromyelitis optica spectrum disorders, and myelin oligodendrocyte glycoprotein antibody-associated disease. |
2024-06-28 |
2024-07-01 |
Not clear |
| Massimo Filippi, Paolo Preziosa, Monica Margoni, Maria A Rocc. Diagnostic Criteria for Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, and Myelin Oligodendrocyte Glycoprotein-immunoglobulin G-associated Disease. Neuroimaging clinics of North America. vol 34. issue 3. 2024-06-28. PMID:38942518. |
diagnostic criteria for multiple sclerosis, neuromyelitis optica spectrum disorders, and myelin oligodendrocyte glycoprotein-immunoglobulin g-associated disease. |
2024-06-28 |
2024-07-01 |
Not clear |
| Massimo Filippi, Paolo Preziosa, Monica Margoni, Maria A Rocc. Diagnostic Criteria for Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, and Myelin Oligodendrocyte Glycoprotein-immunoglobulin G-associated Disease. Neuroimaging clinics of North America. vol 34. issue 3. 2024-06-28. PMID:38942518. |
neuromyelitis optica spectrum disorders (nmosd) and myelin oligodendrocyte glycoprotein-immunoglobulin g-associated disease (mogad) are recognized as separate conditions from ms, with specific diagnostic criteria. |
2024-06-28 |
2024-07-01 |
Not clear |